Cancer Treatment and the Ovary

Preclinical Approaches to the Protection of Ovarian Function

9.1 Introduction Recent advances in our understanding of the mechanisms underlying the impact of cytotoxic drugs on the ovary have opened up new directions for the protection of ovarian function from chemotherapy-induced damage. Studies are providing greater detail as to…

Ovarian Tissue Cryopreservation for Fertility Preservation

7.1 Overview The survival rate among the ~2% of women of reproductive age who have suffered from invasive cancer has substantially increased. Unfortunately, the necessary chemo- and radiotherapy carry the risk of unwanted side effects such as permanent infertility, jeopardizing…

In Vitro Models of Ovarian Toxicity

6.1 Introduction Investigating the precise effect of chemotherapy on female fertility is a key research aspect underpinning fertility-preservation work. Protecting the ovarian follicle pool will require detailed understanding of precisely how the different chemotherapy drugs damage the ovary: whether chemotherapy…

In Vivo Models of Ovarian Toxicity

5.1 Introduction The success of cancer treatment creates a growing population of female cancer survivors who wrestle with long-term side effects of chemotherapy, including primary ovarian insufficiency (POI). This growing survivorship presents researchers and clinicians with the challenging mandate to…

Clinical Assessment of Ovarian Toxicity

3.1 Introduction Assessment of ovarian toxicity in the clinical setting is important in determining the effects of exposures on individual women and to compare different exposures in groups of women, for example those on different chemotherapy regimens. Such knowledge can…